This year will probably go down as the roughest year for investors since the financial recession in 2008. The S&P 500 has shed more than 20% of its value year-to-date as inflation and interest rates weigh down the equities market. Hence, investors are scrambling to streamline their portfolios. In doing so, they might want to
0 Comments
Sometimes, it’s hard to know who or what to believe. Such is the case when it comes to the ongoing U.S. Securities and Exchange Commission (SEC) probe into Cassava Sciences (NASDAQ:SAVA). As the biopharmaceutical company contends with data-manipulation allegations, traders have to figure out what to do with SAVA stock. There may be evidence that the
0 Comments
It’s been a tumultous couple of years of real estate stocks. The pandemic caused unprecedented changes in people’s daily lives and working habits. Some categories of real estate investment trusts (REITs) benefitted from these adjustments. Sub-sectors such as data centers and industrial warehouses enjoyed a surge in demand during the pandemic period. Many categories of
0 Comments
With stocks still in a bear market, adding dividend stocks may look very appealing right now. Even if the overall market keeps dropping, stocks with steady payouts could still produce positive returns for your portfolio. However, while there are opportunities out there for income-focused investors, there are also plenty of dividend stocks to sell if
0 Comments
If your company offers a 401(k) retirement savings plan, as most do, one of the big questions you may have to answer is this: Which version do you want—traditional or Roth? The question is whether you will contribute to your retirement in pre-tax money or post-tax money. The short answer is that saving pre-tax money
0 Comments
Lauren Taylor Wolfe, center, Roy Swan, left, and Shundrawn Thomas at CNBC’s Delivering Alpha, Sept. 8, 2022. Scott Mlyn | CNBC ESG and sustainable investing generally have come under fire recently, with critics pointing to a lack of transparency and differing definitions sparking confusion around what investors are actually buying. Adding to the confusion is
0 Comments
Even though the stock market has performed miserably lately, and throughout most of 2022, macroeconomic data shows there is reason to be hopeful equities can rebound meaningfully sooner rather than later. Moreover, unlike in April, May and June, a significant number of non-defensive stocks across numerous sectors are holding their own and even advancing on
0 Comments
This year, consumer stocks have been hammered as inflation lingers at 40-year highs and interest rates rise. The Dow Jones U.S. Consumer Goods Index is down 20% this year as consumers pull back on their spending. However, some consumer-focused companies have performed worse than others. Much worse.  Whether it is due to poor management, failure to adapt
0 Comments
In this article LYFT AAPL OCGN THO DIS BIIB Follow your favorite stocksCREATE FREE ACCOUNT Check out the companies making headlines before the bell: Biogen (BIIB) – Biogen soared 45.6% in premarket trading after Biogen and Japanese partner Eisai said their experimental Alzheimer’s drug dramatically slowed the disease’s progression in a study, reducing cognitive and
0 Comments